← All organizations

Perrigo

For profit

Also known as: ACO Hud Nordic AB | L PERRIGO CO | PERRIGO | PERRIGO CO | Perrigo Company | PERRIGO CO TENNESSEE | Perrigo CSCI | PERRIGO ISRAEL | PERRIGO NEW YORK | PERRIGO PHARMA INTERNATIONAL DAC | PERRIGO PHARMA INTL | PERRIGO PHARMS CO | PERRIGO R AND D | PERRIGO UK FINCO | PERRIGO UK FINCO LTD PARTNERSHIP | PLD ACQUISITIONS LLC | ROSEMONT PHARMS

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Oct 7, 2025

Timeline

1880s

Jan 1, 1887
Perrigo— Founded

1990s

Feb 7, 1997
butoconazole— NDA Secondary Org

2010s

Jan 1, 2011
Paddock Laboratories— Acquired
Dec 28, 2012
Cobrek Pharmaceuticals— Acquired
Jan 1, 2013
Elan Pharmaceuticals— Acquired
Aug 9, 2013
fluocinolone acetonide— Marketing Organization
May 9, 2019
Ranir— Acquired

2020s

Sep 8, 2021
HRA Pharma— Acquired

Drugs by trial phase (58 distinct, 93 trials)

Phase 4 (4 own, 9 via acquisition)

Phase 3 (18 own, 5 via acquisition)

Phase 2 (3 own, 7 via acquisition)

Phase 1 (3 own, 5 via acquisition)

Other trials (4 own, 0 via acquisition)

Subsidiaries (5 direct, 10 total across the full acquisition tree)

Recent trials (41)

NCT04944290Lead sponsorPhase 3May 28, 2021
NCT04749784Lead sponsorN/AOct 30, 2020
NCT04155203Lead sponsorPhase 3Oct 15, 2019
NCT04024072Lead sponsorPhase 3Jun 24, 2019
NCT03901144Lead sponsorPhase 2Feb 21, 2019
NCT03518268CollaboratorPhase 1/Phase 2Oct 31, 2018
NCT03393494Lead sponsorPhase 3Dec 13, 2017
NCT03352323Lead sponsorPhase 3Oct 18, 2017
NCT02800148Lead sponsorPhase 3Nov 1, 2016
NCT02800824Lead sponsorPhase 1Jun 7, 2016
NCT02770365Lead sponsorPhase 3May 1, 2016
NCT02795117Lead sponsorPhase 3May 1, 2016
NCT02515305Lead sponsorPhase 3Jul 1, 2015
NCT02459795Lead sponsorPhase 3May 1, 2015
NCT02385240Lead sponsorPhase 3Mar 1, 2015

Details

Founded: Allegan, MI, US Jan 1, 1887
Last known activity: Oct 7, 2025